Get the Stockscreener App
18.72
1.06%
-0.20
Innoviva Inc stock is traded at $18.72, with a volume of 885.57K.
It is down -1.06% in the last 24 hours and down -8.59% over the past month.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
See More
Previous Close:
$18.92
Open:
$18.92
24h Volume:
885.57K
Relative Volume:
1.05
Market Cap:
$1.18B
Revenue:
$330.50M
Net Income/Loss:
$145.42M
P/E Ratio:
11.35
EPS:
1.65
Net Cash Flow:
$157.96M
1W Performance:
-4.34%
1M Performance:
-8.59%
6M Performance:
+0.11%
1Y Performance:
+2.91%
1-Day Range:
$18.65
$19.01
1-Week Range:
$18.65
$19.69
52-Week Range:
$16.67
$22.00
Innoviva Inc Stock (INVA) Company Profile
Name
Innoviva Inc
Sector
Industry
Phone
(650) 238-9600
Address
1350 OLD BAYSHORE HIGHWAY, BURLINGAME
Compare INVA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INVA
Innoviva Inc
|
18.72 | 1.19B | 330.50M | 145.42M | 157.96M | 1.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Innoviva Inc Stock (INVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-14-25 | Initiated | H.C. Wainwright | Buy |
| Jul-11-25 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-07-25 | Initiated | Scotiabank | Sector Outperform |
| Jun-18-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-20-22 | Initiated | Goldman | Neutral |
| Nov-20-17 | Initiated | Deutsche Bank | Hold |
View All
Innoviva Inc Stock (INVA) Latest News
Is Innoviva Inc. a good long term investmentTriple-digit return opportunities - PrintWeekIndia
What drives Innoviva Inc. stock priceAccelerated investment success - PrintWeekIndia
What analysts say about Innoviva Inc. stockPhenomenal capital gains - PrintWeekIndia
What risks could impact Innoviva Inc. stock performanceMarket Ready Callouts - Newser
Innoviva Inc. Stock Analysis and ForecastExceptional market performance - Autocar Professional
Teacher Retirement System of Texas Reduces Stock Holdings in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Financial Analysis: Innoviva (NASDAQ:INVA) versus Bayer Aktiengesellschaft (OTCMKTS:BAYRY) - Defense World
Innoviva (NASDAQ:INVA) & Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Financial Review - Defense World
Equities Analysts Set Expectations for Innoviva Q2 Earnings - Defense World
Innoviva, Inc. (NASDAQ:INVA) Shares Acquired by Principal Financial Group Inc. - Defense World
(INVA) Proactive Strategies - news.stocktradersdaily.com
Innoviva (NASDAQ:INVA) Coverage Initiated at HC Wainwright - Defense World
What makes Innoviva Inc. stock price move sharplyTop Gaining Low Risk Assets - Newser
How Innoviva Inc. stock performs during market volatilityFree Exclusive Group - Newser
Why Innoviva Inc. stock attracts strong analyst attentionFree Growth Investment Group - Newser
H.C. Wainwright Initiates Innoviva(INVA.US) With Buy Rating, Announces Target Price $40 - 富途牛牛
HC Wainwright Initiates Innoviva at Buy With $40 Price Target - MarketScreener
This Cisco Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Cantor Fitzgerald Predicts Innoviva FY2026 Earnings - Defense World
Cantor Fitzgerald Begins Coverage on Innoviva (NASDAQ:INVA) - Defense World
Innoviva, Inc. shares rise 2.05% premarket after Jazz Pharmaceuticals announces CEO succession plan. - AInvest
New York State Teachers Retirement System Sells 3,448 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva, Inc. (NASDAQ:INVA) Shares Sold by Allspring Global Investments Holdings LLC - Defense World
Head to Head Analysis: Merck & Co., Inc. (NYSE:MRK) versus Innoviva (NASDAQ:INVA) - Defense World
(INVA) Long Term Investment Analysis - news.stocktradersdaily.com
Illinois Municipal Retirement Fund Sells 1,260 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva Inc Stock (INVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Innoviva Inc Stock (INVA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| DENNER ALEXANDER J | 10% Owner |
Mar 05 '25 |
Sale |
17.63 |
270,374 |
4,766,126 |
6,855,451 |
| DENNER ALEXANDER J | 10% Owner |
Mar 04 '25 |
Sale |
17.63 |
151,175 |
2,665,079 |
7,125,825 |
0.97%
0.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):